Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


25.03.2024

2 Am Heart J
4 Am J Cardiol
1 Am J Med
3 Ann Intern Med
1 Arterioscler Thromb Vasc Biol
1 Atherosclerosis
1 BMJ
3 Can J Cardiol
8 Catheter Cardiovasc Interv
4 Circ Cardiovasc Imaging
7 Circ Cardiovasc Interv
5 Circ Cardiovasc Qual Outcomes
1 Circ Genom Precis Med
3 Circ Heart Fail
5 Circulation
1 Clin Cardiol
1 Curr Opin Cardiol
1 Eur Heart J
3 Int J Cardiol
1 J Clin Endocrinol Metab
4 J Electrocardiol
1 J Thorac Cardiovasc Surg
7 JAMA
8 Lancet
1 Mayo Clin Proc
5 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. WU Y, Hu L, Xie X, Li W, et al
    Different Dose Aspirin Plus Immunoglobulin (DAPI) for Prevention of Coronary Artery Abnormalities in Kawasaki Disease: Study Protocol for a Multi-centre, Prospective, Randomized, Open-label, Blinded End-point, Non-inferiority Trial.
    Am Heart J. 2024 Mar 18:S0002-8703(24)00071-1. doi: 10.1016/j.ahj.2024.
    PubMed         Abstract available

  2. ALVIAR CL, Li BK, Keller NM, Bohula-May E, et al
    Prognostic Performance of the IABP-SHOCK II Risk Score Among Cardiogenic Shock Subtypes in the Critical Care Cardiology Trials Network Registry.
    Am Heart J. 2024 Jan 6:S0002-8703(23)00361-7. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available


    Am J Cardiol

  3. ABDUL-KAFI OS, Vidovich MI
    Coronary Calcification Optical Coherence Tomography-Another Brick in the Wall.
    Am J Cardiol. 2024 Mar 13:S0002-9149(24)00194.
    PubMed        

  4. OZAKI Y, Kitabata H, Takahata M, Katayama Y, et al
    Intracoronary Near-Infrared Spectroscopy to Predict No-Reflow Phenomenon During Percutaneous Coronary Intervention in Acute Coronary Syndrome.
    Am J Cardiol. 2024 Mar 13:S0002-9149(24)00173.
    PubMed         Abstract available

  5. BONARJEE VV
    A comparison of Ultrathin struts drug eluting stents.
    Am J Cardiol. 2024 Mar 14:S0002-9149(24)00193.
    PubMed        

  6. BENENATI S, Giacobbe F, Macaya F, Patti G, et al
    Impaired culprit-vessel flow affects percutaneous coronary intervention outcomes in spontaneous coronary artery dissections.
    Am J Cardiol. 2024 Mar 15:S0002-9149(24)00195.
    PubMed        


    Am J Med

  7. ROOS A, Edgren G
    High-Sensitivity Cardiac Troponins in Patients with Chest Pain and Treatment With Oral Antineoplastic Agents Associated With Cardiovascular Toxicity.
    Am J Med. 2024 Mar 13:S0002-9343(24)00143-8. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available


    Ann Intern Med

  8. YONIS H, Granger CB
    In adults aged >/=80 y with NSTE-ACS, an invasive vs. conservative strategy improved outcomes at a median 5.3 y.
    Ann Intern Med. 2024;177:JC27.
    PubMed         Abstract available

  9. BAVISHI C
    In adults with stable angina, PCI vs. a placebo procedure reduced angina symptoms at 12 wk.
    Ann Intern Med. 2024;177:JC28.
    PubMed         Abstract available

  10. MUKHERJEE D
    In acute MI and anemia, restrictive vs. liberal transfusion did not differ for a composite of recurrent MI or death at 30 d.
    Ann Intern Med. 2024 Mar 5. doi: 10.7326/J24-0010.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  11. BUCKLEY LF, Libby P
    Role of Colchicine in Cardiovascular Disease Management.
    Arterioscler Thromb Vasc Biol. 2024 Mar 21. doi: 10.1161/ATVBAHA.124.319851.
    PubMed         Abstract available


    Atherosclerosis

  12. REXHAJ E, Bar S, Soria R, Ueki Y, et al
    Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
    Atherosclerosis. 2024;392:117504.
    PubMed         Abstract available


    BMJ

  13. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    PubMed         Abstract available


    Can J Cardiol

  14. SAADA M, Lavi S
    Angiography-Derived Index of Microvascular Resistance: A New Frontier in the Management of Patients With Coronary Artery Disease.
    Can J Cardiol. 2024;40:444-446.
    PubMed        

  15. CHEN L, Sang C, Wu Y, Chen W, et al
    Coronary Angiography-Derived Index of Microcirculatory Resistance Associated With New-Onset Atrial Fibrillation in Patients With STEMI.
    Can J Cardiol. 2024;40:434-443.
    PubMed         Abstract available

  16. SHOWKATHALI R, Yalamanchi RP, Kumar AM, Cs V, et al
    Isolated Giant Right Coronary Aneurysm Associated With IgG4-Related Disease.
    Can J Cardiol. 2024;40:447-449.
    PubMed        


    Catheter Cardiovasc Interv

  17. VELAGALETI RS, Harrell C, Michalski J, Lefevre T, et al
    Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Mar 5. doi: 10.1002/ccd.30995.
    PubMed         Abstract available

  18. FILHO EM, Araujo GN, Machado GP, Padilla L, et al
    Guide catheter extension use are associated with higher procedural success in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2024 Mar 3. doi: 10.1002/ccd.30987.
    PubMed         Abstract available

  19. SOLA M, Kay J, Messenger J, Zablah J, et al
    Transcatheter closure of a large coronary cameral fistula presenting as a calcified cystic right atrial mass.
    Catheter Cardiovasc Interv. 2024;103:607-611.
    PubMed         Abstract available

  20. SCIAHBASI A, Salvi N, Heang TM, Perez IS, et al
    Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels.
    Catheter Cardiovasc Interv. 2024;103:532-538.
    PubMed         Abstract available

  21. SCHELLER B
    Drug-coated balloons for complex coronary de novo lesions.
    Catheter Cardiovasc Interv. 2024;103:688-689.
    PubMed        

  22. ALEKSANDRIC S, Beleslin B
    Editorial comment: SYNTAX score II 2020 as a tool for decision making on revascularization strategy in high-risk patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2024;103:680-681.
    PubMed        

  23. POLETTI E, Zivelonghi C, Dens J, Bennett J, et al
    Performance of the minimalistic hybrid approach algorithm versus other conventional algorithms in the percutaneous treatment of chronic total occlusions.
    Catheter Cardiovasc Interv. 2024;103:548-559.
    PubMed         Abstract available

  24. SINGH K, Niranjan S, Hibbert B, Taramasso M, et al
    A stepwise approach to coronary artery stenting in acute type A aortic dissection.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30964.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  25. WU X, Wang K, Li G, Wu J, et al
    Diagnostic Performance of Angiography-Derived Quantitative Flow Ratio in Complex Coronary Lesions.
    Circ Cardiovasc Imaging. 2024;17:e016046.
    PubMed         Abstract available

  26. DUNDAS J, Leipsic J, Fairbairn T, Ng N, et al
    Interaction of AI-Enabled Quantitative Coronary Plaque Volumes on Coronary CT Angiography, FFR(CT), and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry.
    Circ Cardiovasc Imaging. 2024 Mar 12:e016143.
    PubMed         Abstract available

  27. YOPES MC, Larnard EA, Liu SD, Stout JL, et al
    Kounis Syndrome After Administration of Ultrasound Enhancing Agent.
    Circ Cardiovasc Imaging. 2024 Feb 28:e016362.
    PubMed        

  28. WARISAWA T, Akasaka T
    Imaging-Based FFR: How Many Steps Toward Replacement for Wire-Based FFR on A Journey of A Thousand Miles.
    Circ Cardiovasc Imaging. 2024;17:e016700.
    PubMed        


    Circ Cardiovasc Interv

  29. MADAN M
    Left Main Coronary Artery Intervention: Respect the Circumflex.
    Circ Cardiovasc Interv. 2024;17:e014001.
    PubMed        

  30. CAMPO G, Erriquez A, Biscaglia S
    Perfect Wedding Between Patient With STEMI and Angiography-Derived Indexes of Coronary Physiology.
    Circ Cardiovasc Interv. 2024 Feb 20:e013944.
    PubMed        

  31. SCARSINI R, Kotronias RA, Della Mora F, Portolan L, et al
    Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI.
    Circ Cardiovasc Interv. 2024 Feb 20:e013556.
    PubMed         Abstract available

  32. PRICE AL, Amin AP, Rogers S, Messenger JC, et al
    Implementation of a Multidimensional Strategy to Reduce Post-PCI Bleeding Risk.
    Circ Cardiovasc Interv. 2024;17:e013003.
    PubMed         Abstract available

  33. AMAT-SANTOS IJ, Marengo G, Cortes C, Sanchez-Luna JP, et al
    Response by Amat-Santos et al to Letter Regarding Article, "Laser Coronary Atherectomy and Polymeric Coronary Wires in Uncrossable Lesions: a Word of Caution".
    Circ Cardiovasc Interv. 2024;17:e013996.
    PubMed        

  34. JURADO-ROMAN A, Wacinski PJ, Egred M
    Letter by Jurado-Roman et al Regarding Article, "Laser Coronary Atherectomy and Polymeric Coronary Wires in Uncrossable Lesions: A Word of Caution".
    Circ Cardiovasc Interv. 2024;17:e013954.
    PubMed        

  35. ALI ZA, Garcia JJ, Karimi Galougahi K, Horst J, et al
    Impact of Incomplete Revascularization After PCI in Left Main Disease: The EXCEL Trial.
    Circ Cardiovasc Interv. 2024;17:e013192.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  36. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Nowbar AN, et al
    Why Does a Cardiologist Believe in a Therapy? The Role of Intuitiveness and Understanding the Mechanism.
    Circ Cardiovasc Qual Outcomes. 2024;17:e010664.
    PubMed        

  37. MSZAR R, Mszar E
    Familial Hypercholesterolemia and Our Family's Heart History: From Atherosclerosis and Angina to Awareness and Advocacy.
    Circ Cardiovasc Qual Outcomes. 2024 Feb 15:e010864.
    PubMed        

  38. RAZAVI AC, Kohli P, McGuire DK, Martin SS, et al
    PREVENT Equations: A New Era in Cardiovascular Disease Risk Assessment.
    Circ Cardiovasc Qual Outcomes. 2024 Mar 20:e010763.
    PubMed        

  39. KHERA R, Wiens J
    Summertime for Cardiovascular AI.
    Circ Cardiovasc Qual Outcomes. 2024;17:e010404.
    PubMed        

  40. KORJIAN S, Baron SJ
    Seeing Beyond the Surface: Is Intravascular Imaging Cost-Effective?
    Circ Cardiovasc Qual Outcomes. 2024 Mar 13:e010745.
    PubMed        


    Circ Genom Precis Med

  41. KRYSOV VA, Wilson RH, Ten NS, Youlton N, et al
    Regional Variation in Cardiovascular Genes Enables a Tractable Genome Editing Strategy.
    Circ Genom Precis Med. 2024 Mar 20:e004370. doi: 10.1161/CIRCGEN.123.004370.
    PubMed         Abstract available


    Circ Heart Fail

  42. L'HOYES W, Rosseel T, Jacobs B, Van Edom C, et al
    Blood Speckle Imaging in Critical Care: A New Tool in Mechanical Circulatory Support Management.
    Circ Heart Fail. 2024 Feb 8:e010697. doi: 10.1161/CIRCHEARTFAILURE.123.010697.
    PubMed        

  43. BLUMER V, Kanwar MK, Psotka MA
    Rethinking the Nomenclature of Heart Failure Cardiogenic Shock: Do We Need to Start De Novo?
    Circ Heart Fail. 2024 Feb 29:e011180. doi: 10.1161/CIRCHEARTFAILURE.123.011180.
    PubMed        

  44. LU DY, Kanduri J, Yeo I, Goyal P, et al
    Impact of Advanced Therapy Centers on Characteristics and Outcomes of Heart Failure Admissions.
    Circ Heart Fail. 2024 Mar 8:e011115. doi: 10.1161/CIRCHEARTFAILURE.123.011115.
    PubMed         Abstract available


    Circulation

  45. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
    A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
    Circulation. 2024;149:902-904.
    PubMed        

  46. EVERETT BM
    The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
    Circulation. 2024;149:914-916.
    PubMed        

  47. MARANO P, Mouapi K, Kim A, Mastali M, et al
    Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
    Circulation. 2024;149:970-972.
    PubMed        

  48. FRANGOGIANNIS NG
    Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e962-e963.
    PubMed        

  49. TENG Z, Ma Y, Ma X
    Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
    Circulation. 2024;149:e960-e961.
    PubMed        


    Clin Cardiol

  50. LEI H, Zhu L, Zhang X
    Knowledge, attitude, and practice toward postoperative self-management among patients after percutaneous coronary intervention: A structural equation modeling analysis.
    Clin Cardiol. 2024;47:e24232.
    PubMed         Abstract available


    Curr Opin Cardiol

  51. SINHA A, Rahman H, Perera D
    Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
    Curr Opin Cardiol. 2023;38:521-526.
    PubMed         Abstract available


    Eur Heart J

  52. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    PubMed        


    Int J Cardiol

  53. XU P, Cao Y, Zhang S, Liu X, et al
    The predictive value of serum Dickkopf-1, Dickkopf-3 level to coronary artery disease and acute coronary syndrome.
    Int J Cardiol. 2024;403:131887.
    PubMed         Abstract available

  54. SAMPAIO RODRIGUES T, Narendren A, Cailes B, Lim RP, et al
    Enhancing pre-transplant cardiac assessment: Validation and utility of the CAD-LT score with CCTA in liver transplant candidates.
    Int J Cardiol. 2024;403:131895.
    PubMed         Abstract available

  55. DOUGHTY A, Keane G, Wadley AJ, Mahoney B, et al
    Plasma concentrations of thioredoxin, thioredoxin reductase and peroxiredoxin-4 can identify high risk patients and predict outcome in patients with acute coronary syndrome: A clinical observation.
    Int J Cardiol. 2024;403:131888.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  56. VAN DER VALK ES, Mohseni M, Iyer AM, van den Hurk M, et al
    Long-term glucocorticoid exposure and incident cardiovascular diseases - the Lifelines cohort.
    J Clin Endocrinol Metab. 2024 Mar 19:dgae081. doi: 10.1210.
    PubMed         Abstract available


    J Electrocardiol

  57. RUEDA-OCHOA OL, Osorio-Romero LF, Sanchez-Mendez LD
    Which indices of heart rate variability are the best predictors of mortality after acute myocardial infarction? Meta-analysis of observational studies.
    J Electrocardiol. 2024;84:42-48.
    PubMed         Abstract available

  58. MANSOUR M, Alqaisi O, Gautam N, Vallurupalli S, et al
    Significance of abnormal stress electrocardiography with normal cardiac imaging during stress testing-a meta-analysis.
    J Electrocardiol. 2024;83:64-70.
    PubMed         Abstract available

  59. VAN DER SCHAAF I, Kloosterman M, Gorgels APM, Loh P, et al
    CineECG for visualization of changes in ventricular electrical activity during ischemia.
    J Electrocardiol. 2024;83:50-55.
    PubMed         Abstract available

  60. GEFFIN R, Triska J, Najjar S, Berman J, et al
    Why do we keep missing left circumflex artery myocardial infarctions?
    J Electrocardiol. 2024;83:4-11.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  61. ALZAHRANI AH, Itagaki S, Egorova N, Chikwe J, et al
    Choice of revascularization strategy for ischemic cardiomyopathy due to multi-vessel coronary disease.
    J Thorac Cardiovasc Surg. 2024 Mar 14:S0022-5223(24)00208.
    PubMed         Abstract available


    JAMA

  62. CHEN G, Shang M, Yang Y
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction-Reply.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0617.
    PubMed        

  63. ZAKIEV V, Gvozdeva A, Skotnikov A
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0620.
    PubMed        

  64. ASHAM H, Entezari-Maleki T
    Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.
    JAMA. 2024 Mar 20. doi: 10.1001/jama.2024.0623.
    PubMed        

  65. HARRIS E
    Blood Test Predicted Risk of Future Heart Attacks.
    JAMA. 2024;331:908.
    PubMed        

  66. HARRIS E
    Meta-Analysis: Cardiovascular Risks Rose After Stopping Aspirin.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2091.
    PubMed        

  67. XU J
    Sintilimab and Cardiovascular Toxicity-Reply.
    JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0676.
    PubMed        

  68. PENG L, Yang D, Weng C
    Sintilimab and Cardiovascular Toxicity.
    JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.0673.
    PubMed        


    Lancet

  69. RIDKER PM, Bhatt DL, Nissen SE
    Inflammation, infection, and cardiovascular risk - Authors' reply.
    Lancet. 2024;403:1025-1026.
    PubMed        

  70. SHARMA S, Sharma R
    Inflammation, infection, and cardiovascular risk.
    Lancet. 2024;403:1024-1025.
    PubMed        

  71. GOLDMAN M, Bondue A, Cogan E
    Inflammation, infection, and cardiovascular risk.
    Lancet. 2024;403:1023.
    PubMed        

  72. GOLDSTEIN MR, Mascitelli L
    Inflammation, infection, and cardiovascular risk.
    Lancet. 2024;403:1023-1024.
    PubMed        

  73. DROZD M, Cubbon R
    Inflammation, infection, and cardiovascular risk.
    Lancet. 2024;403:1022-1023.
    PubMed        

  74. PAREEK A, Chandurkar N, Naidu K, Raut V, et al
    Inflammation, infection, and cardiovascular risk.
    Lancet. 2024;403:1022.
    PubMed        

  75. STRANDBERG TE, Kovanen PT, Gylling H
    Inflammation, infection, and cardiovascular risk.
    Lancet. 2024;403:1021.
    PubMed        

  76. LIN GM, Huang WC, Han CL
    Inflammation, infection, and cardiovascular risk.
    Lancet. 2024;403:1021-1022.
    PubMed        


    Mayo Clin Proc

  77. KNOTT JD, Ola O, De Michieli L, Akula A, et al
    High Baseline High-Sensitivity Cardiac Troponin T Concentrations and Risk of Index Acute Myocardial Infarction.
    Mayo Clin Proc. 2024 Mar 15:S0025-6196(24)00026.
    PubMed         Abstract available


    N Engl J Med

  78. WHITE HD
    A Placebo-Controlled Trial of PCI for Stable Angina. Reply.
    N Engl J Med. 2024;390:10.
    PubMed        

  79. AL-LAMEE RK, Rajkumar CA
    A Placebo-Controlled Trial of PCI for Stable Angina. Reply.
    N Engl J Med. 2024;390:1151-1152.
    PubMed        

  80. DURANTE A, Baiardo Redaelli M
    A Placebo-Controlled Trial of PCI for Stable Angina.
    N Engl J Med. 2024;390:1150-1151.
    PubMed        

  81. SHERROD CF 4TH, O'Keefe EL, Ikemura N
    A Placebo-Controlled Trial of PCI for Stable Angina.
    N Engl J Med. 2024;390:1150.
    PubMed        

  82. BESTERMANN WH JR
    A Placebo-Controlled Trial of PCI for Stable Angina.
    N Engl J Med. 2024;390:1149-1150.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.